Gabrielle Bangay

Gabrielle Bangay is a Researcher at the School of Health Sciences and Technologies (ECTS) of Universidade Lusófona de Humanidades e Tecnologias, affiliated with the Research Center for Biosciences & Health Technologies (CBIOS). Her work focuses on pharmacology, natural product-based anticancer therapies, and multidrug resistance reversal mechanisms.

• Key Research Areas: Pharmacology, Medicinal Chemistry, Natural Product Research
• Collaborations: Active in international collaborations, particularly in cancer research and phytochemical studies.

Her recent publications highlight the use of diterpenoids like royleanones and abietane derivatives for targeting P-glycoprotein in cancer therapy, functionalized gold nanoparticles for drug delivery, and systematic reviews of Plectranthus amboinicus in traditional and modern medicine. These studies integrate experimental and computational approaches to address neurotoxicity, antifungal properties, and cytotoxicity.

Current projects include ABC-MDR-REVERSAL, which investigates allosteric mechanisms to overcome multidrug resistance in cancer via ATP-binding cassette transporters. Her work bridges natural product chemistry with translational applications in oncology and neuroprotection.